Moderna shares rise 6% after the FDA reversed its decision not to review the flu vaccine
Following an earlier surge in pre-market trading, Moderna shares increased 6.4% to approximately $46.75 shortly after the market started on...
novel flu vaccine
Following an earlier surge in pre-market trading, Moderna shares increased 6.4% to approximately $46.75 shortly after the market started on...
